Akoya

Akoya Biosciences stock has undergone multiple analysts rating changes in the recent past.  Akoya Biosciences Upgraded by Zacks Investment Research on 10-12-21. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Sell.

Shares of Akoya Biosciences traded down -$0.55 on Tuesday, reaching $12.24. 0 shares of the stock traded hands, compared to its average volume of 95515. Shares of Akoya Biosciences were trading at $12.24 on Tuesday. The firm’s 50 day moving average is $15.68 and its 200 day moving average is N/A.Akoya Biosciences has a 12 month low of $12.07 and a 12 month high of $28.96. While on yearly highs and lows, Akoya Biosciences’s today has traded high as $13.15 and has touched $12.07 on the downward trend. See More Analyst Rating at: >RATING

Akoya Biosciences Earnings and What to expect: 

Akoya Biosciences last announced its quarterly earnings results on August 9th, 2021. The reported ($0.20) earnings per share for the quarter, beating the consensus estimate of ($0.23) by $0.03. The firm earned $13.07 million during the quarter, compared to analyst estimates of $12.46 million. Akoya Biosciences has generated $0.00 earnings per share over the last year. Earnings for Akoya Biosciences are expected to decrease in the coming year, from ($0.59) to ($0.90) per share. Akoya Biosciences has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Tuesday, November 9th, 2021 based off prior year’s report dates.

Earnings for Akoya Biosciences are expected to decrease in the coming year, from ($0.59) to ($0.90) per share.

Akoya Biosciences (NASDAQ:AKYA) Moving Average Technical Analysis

5 day Moving Average is $12.67 And 5 day price change is -$0.93 (-7.06%)  with average volume for 5 day average is 85,180. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $15.18 and 20 day price change is -$2.14 (-14.88%) and average 20 day moving volume is 109,925. 50 day moving average is $15.68  and 50 day price change is -$4.34 ( -26.18%)  and with average volume for 50 days is : 100,488. 200 day moving average is N/A  and 200 day price change is N/A (N/A)  and with average volume for 200 days is : N/A.

Other owners latest trading in Akoya Biosciences :

  • On 8/25/2021 shares held by Marshall Wace LLP were 24,357 which equates to market value of $0.47M and appx 0.00% owners of Akoya Biosciences
  • On 8/23/2021 shares held by Morgan Stanley were 110,502 which equates to market value of $2.14M and appx 0.00% owners of Akoya Biosciences
  • On 8/18/2021 shares held by Blackstone Inc were 50,000 which equates to market value of $0.97M and appx 0.00% owners of Akoya Biosciences
  • In total Institutional ownership equates to Institutional Ownership Percentage: 26.85% for Akoya Biosciences

See More Analyst Rating at: >RATING

Source : https://stockmarketdaily.co/2021/10/13/akoya-biosciences-nasdaqakya-upgraded-by-zacks-investment-research-to-hold/

527
Jack Henry, Provider of Payments Processing for Financial Services Sector, Integrates with Finicity, Akoya, Plaid

Source:Crowdfund Insider

Jack Henry, Provider of Payments Processing for Financial Services Sector, Integrates with Finicity, Akoya, Plaid

Jack Henry partners with Open Banking providers to enhance Digital Platform

Source:IBS

Jack Henry partners with Open Banking providers to enhance Digital Platform

Jack Henry Partners with Open Banking Providers to Enhance Digital Platform

Source:PR Newswire

Jack Henry Partners with Open Banking Providers to Enhance Digital Platform